Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.25.3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Aug. 31, 2023   $ 80 $ 174,689 $ (56,535) $ 118,234
Balance (in shares) at Aug. 31, 2023 432,513 24,078,720      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock grants     44   44
Restricted stock grants (in shares)   8,000      
Stock options exercised (in shares)   17,456      
Stock granted for services     195   195
Stock granted for services (in shares)   19,644      
Share-based compensation     197   197
Repurchases of common stock       (581) (581)
Repurchases of common stock (in shares)   (59,926)      
Net income       11,613 11,613
Balance at Aug. 31, 2024   $ 80 175,125 (45,503) 129,702
Balance (in shares) at Aug. 31, 2024 432,513 24,063,894      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock grants     21   21
Restricted stock grants (in shares)   9,200      
Stock options exercised (in shares)   13,815      
Stock granted for services     180   180
Stock granted for services (in shares)   15,396      
Share-based compensation     122   122
Repurchases of common stock       (397) (397)
Repurchases of common stock (in shares)   (35,500)      
Net income       13,110 13,110
Balance at Aug. 31, 2025   $ 80 $ 175,448 $ (32,790) $ 142,738
Balance (in shares) at Aug. 31, 2025 432,513 24,066,805